I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 5 studies | 25% ± 6% | |
| epithelial cell | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 32% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 5 studies | 25% ± 6% | |
| epithelial cell | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 32% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 602.03 | 459 / 459 | 100% | 6.57 | 1118 / 1118 |
| prostate | 100% | 573.12 | 245 / 245 | 100% | 5.80 | 502 / 502 |
| uterus | 100% | 637.32 | 170 / 170 | 100% | 6.60 | 459 / 459 |
| thymus | 100% | 604.69 | 653 / 653 | 100% | 5.43 | 604 / 605 |
| ovary | 100% | 566.91 | 180 / 180 | 100% | 4.57 | 429 / 430 |
| brain | 100% | 506.31 | 2635 / 2642 | 100% | 5.19 | 705 / 705 |
| skin | 100% | 644.62 | 1807 / 1809 | 100% | 5.02 | 471 / 472 |
| kidney | 100% | 443.88 | 89 / 89 | 99% | 3.50 | 895 / 901 |
| esophagus | 100% | 566.17 | 1443 / 1445 | 99% | 3.79 | 182 / 183 |
| liver | 100% | 313.66 | 225 / 226 | 100% | 2.92 | 404 / 406 |
| adrenal gland | 100% | 668.31 | 257 / 258 | 99% | 4.41 | 228 / 230 |
| bladder | 100% | 562.29 | 21 / 21 | 99% | 4.93 | 497 / 504 |
| pancreas | 99% | 275.67 | 324 / 328 | 99% | 3.78 | 177 / 178 |
| stomach | 100% | 439.39 | 358 / 359 | 98% | 3.80 | 279 / 286 |
| lung | 97% | 441.42 | 562 / 578 | 100% | 4.82 | 1154 / 1155 |
| intestine | 100% | 607.08 | 965 / 966 | 97% | 4.20 | 512 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.96 | 29 / 29 |
| spleen | 100% | 588.82 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.27 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.64 | 1 / 1 |
| adipose | 100% | 561.84 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 565.98 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 491.74 | 801 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 4.41 | 79 / 80 |
| heart | 99% | 424.13 | 850 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 47% | 264.91 | 432 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0050821 | Biological process | protein stabilization |
| GO_0070286 | Biological process | axonemal dynein complex assembly |
| GO_0120293 | Cellular component | dynein axonemal particle |
| GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
| GO_0005515 | Molecular function | protein binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| Gene name | DNAAF10 |
| Protein name | Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) (WD repeat-containing protein Monad) Dynein axonemal assembly factor 10 |
| Synonyms | DKFZp434B156 WDR92 |
| Description | FUNCTION: Key assembly factor specifically required for the stability of axonemal dynein heavy chains in cytoplasm. . FUNCTION: Key assembly factor specifically required for the stability of axonemal dynein heavy chains in cytoplasm. . |
| Accessions | Q96MX6 Q8ND98 ENST00000295121.11 [Q96MX6-1] ENST00000406245.6 ENST00000457114.5 ENST00000409164.1 [Q96MX6-2] H7C389 |
